Novo Nordisk A/S | NOVOB - PE Price to Earnings


Novo Nordisk reported 12.78 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Bausch Health Companies 6.98 0.41 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 17.85 2.11 Dec/2025
Novo Nordisk 12.78 0.01 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pacira 52.68 23.44 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025